These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28562348)

  • 21. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections.
    Saiura A; Yamamoto J; Kokudo N; Koga R; Seki M; Hiki N; Yamada K; Natori T; Yamaguchi T
    Am J Surg; 2011 Feb; 201(2):203-8. PubMed ID: 19427630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma.
    Kinoshita M; Kanazawa A; Takemura S; Tanaka S; Kodai S; Shinkawa H; Shimizu S; Murata A; Nishio K; Hamano G; Ito T; Tsukamoto T; Kubo S
    Asian J Endosc Surg; 2020 Jan; 13(1):46-58. PubMed ID: 30924307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma.
    Zhu Y; Zhu Y; Cai F; Zhao J; Liu F
    Cell Biochem Biophys; 2015 Nov; 73(2):455-460. PubMed ID: 27352338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major postoperative complications compromise oncological outcomes of patients with intrahepatic cholangiocarcinoma after curative resection - A 13-year cohort in a tertiary center.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Tsang SHY; Lo CM
    Asian J Surg; 2019 Jan; 42(1):164-171. PubMed ID: 29472064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration.
    Spolverato G; Kim Y; Alexandrescu S; Popescu I; Marques HP; Aldrighetti L; Clark Gamblin T; Miura J; Maithel SK; Squires MH; Pulitano C; Sandroussi C; Mentha G; Bauer TW; Newhook T; Shen F; Poultsides GA; Wallis Marsh J; Pawlik TM
    Ann Surg Oncol; 2015 Jul; 22(7):2218-25. PubMed ID: 25354576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical treatment of intrahepatic cholangiocarcinoma--a single center experience.
    Lanthaler M; Biebl M; Strasser S; Weissenbacher A; Falkeis C; Margreiter R; Nehoda H
    Am Surg; 2010 Apr; 76(4):411-7. PubMed ID: 20420253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma.
    Orimo T; Kamiyama T; Mitsuhashi T; Kamachi H; Yokoo H; Wakayama K; Shimada S; Nagatsu A; Taketomi A
    J Gastroenterol; 2018 Nov; 53(11):1206-1215. PubMed ID: 29721628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.
    Bagante F; Spolverato G; Merath K; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Endo I; Pawlik TM
    Surgery; 2019 Dec; 166(6):983-990. PubMed ID: 31326191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence.
    Chan KM; Tsai CY; Yeh CN; Yeh TS; Lee WC; Jan YY; Chen MF
    BMC Gastroenterol; 2018 Dec; 18(1):180. PubMed ID: 30514231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study.
    Gil E; Joh JW; Park HC; Yu JI; Jung SH; Kim JM
    World J Surg Oncol; 2015 Jul; 13():227. PubMed ID: 26216347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit.
    Saxena A; Chua TC; Sarkar A; Chu F; Morris DL
    J Gastrointest Surg; 2010 Jul; 14(7):1128-38. PubMed ID: 20467830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
    Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
    Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First and repeat liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
    Souche R; Addeo P; Oussoultzoglou E; Herrero A; Rosso E; Navarro F; Fabre JM; Bachellier P
    Am J Surg; 2016 Aug; 212(2):221-9. PubMed ID: 26552996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center.
    Chang ME; Lei HJ; Chen MH; Yeh YC; Li CP; Hung YP; Hsia CY; Liu CA; Chau GY; Chao Y
    J Chin Med Assoc; 2017 Mar; 80(3):140-146. PubMed ID: 28169208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
    Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
    Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma.
    Ahn CS; Hwang S; Lee YJ; Kim KH; Moon DB; Ha TY; Song GW; Lee SG
    ANZ J Surg; 2018 Mar; 88(3):212-217. PubMed ID: 27598539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.